188 filings
8-K
ARGS
Argos Therapeutics Inc
3 May 19
Changes in Registrant's Certifying Accountant
4:10pm
8-K
ARGS
Argos Therapeutics Inc
3 Dec 18
Bankruptcy or Receivership
8:01am
10-Q
2018 Q3
ARGS
Argos Therapeutics Inc
Quarterly report
19 Nov 18
3:13pm
NT 10-Q
ARGS
Argos Therapeutics Inc
14 Nov 18
Notice of late quarterly filing
2:49pm
10-Q
2018 Q2
ARGS
Argos Therapeutics Inc
Quarterly report
20 Aug 18
12:00am
NT 10-Q
4jwyg8lrv3wdeb
15 Aug 18
Notice of late quarterly filing
7:00am
8-K
89143 wph5a15
20 Jul 18
Departure of Directors or Certain Officers
4:30pm
25-NSE
gcm4kf8kddrm4ge
19 Jul 18
Exchange delisting
9:04am
S-8
zo165f7tz20ek42kg7pe
15 May 18
Registration of securities for employees
5:01pm
CT ORDER
5sxo on125bnwfccws
9 May 18
Confidential treatment order
12:25pm
8-K
jheigdu8w6213ym
24 Apr 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
rzprfrg5
19 Apr 18
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives
12:00am
8-K
cyy9t8dv7fjmcjsqcffe
2 Apr 18
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
12:00am
424B5
oayuks f7
2 Apr 18
Prospectus supplement for primary offering
12:00am
8-K
zujm6il988aa
7 Mar 18
Other Events
12:00am
8-K
qhn ibmwapu8tl2nk
16 Feb 18
Other Events
12:00am
8-K
h0krj y0zz69gxic9
5 Feb 18
Entry into a Material Definitive Agreement
12:00am
424B5
g6s9 pfne96pr
2 Feb 18
Prospectus supplement for primary offering
12:00am